Literature DB >> 8956805

Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers.

F Levi1, L Randimbison, V C Te, C La Vecchia.   

Abstract

Data from the Cancer Registries of the Swiss Cantons of Vaud and Neuchâtel were analysed to examine possible associations between skin cancers (including basal cell carcinoma, BCC), non-Hodgkin's lymphomas (NHL) and chronic lymphocytic leukaemias (CLL). Between 1974 and 1993, 1767 cases of NHL, 351 of CLL, 1678 of cutaneous malignant melanoma (CMM), 4131 of squamous cell carcinoma (SCC) and 10575 of BCC were registered, and contributed to a total of 120103 person-years at risk. Following NHL, 36 cases of SCC were registered compared with 5.1 expected, corresponding to a standardised incidence ratio (SIR) of 7.0 (95% confidence interval, CI, 4.9-9.7); 37 cases of BCC were observed compared with 10.2 expected (SIR = 3.6; 95% CI 2.6-5.0). Following CLL, nine cases of SCC were observed compared with 1.8 expected (SIR = 5.0; 95% CI 2.3-9.5) and nine cases of BCC were observed compared with 3.3 expected (SIR = 2.7; 95% CI 1.2-5.2). After SCC, 23 cases at NHL were observed compared with 9.0 expected (SIR = 2.6; 95% CI 1.6-3.8); after BCC, 43 cases of NHL were registered compared with 22.5 expected (SIR = 1.9; 95% CI 1.4-2.6); and after CMM, four cases of NHL were observed compared with 2.0 expected (SIR = 2.0). No significant excess of CLL was recorded following skin cancer, but the absolute numbers were small and the SIR was above unity. The findings of this study, conducted in populations with a high level of ascertainment and registration of skin cancers, confirm an excess of skin cancers including BCC, following NHL and CLL, and an excess of NHL following skin cancers. This may be related to shared aetiological factors such as U.V. radiation and associated immunosuppression. Individual-based data on the relationship between U.V. exposure and lymphoid neoplasms are needed to clarify the issue.

Entities:  

Mesh:

Year:  1996        PMID: 8956805      PMCID: PMC2077229          DOI: 10.1038/bjc.1996.642

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  Site distribution of different types of skin cancer: new aetiological clues.

Authors:  S Franceschi; F Levi; L Randimbison; C La Vecchia
Journal:  Int J Cancer       Date:  1996-07-03       Impact factor: 7.396

2.  Mortality from Hodgkin's disease and other lymphomas in Europe, 1960-1990.

Authors:  F Levi; C La Vecchia; F Lucchini; V C Te; S Franceschi
Journal:  Oncology       Date:  1995 Mar-Apr       Impact factor: 2.935

3.  Second cancers among long-term survivors of non-Hodgkin's lymphoma.

Authors:  L B Travis; R E Curtis; B Glimelius; E Holowaty; F E Van Leeuwen; C F Lynch; J Adami; M Gospodarowicz; S Wacholder; P Inskip
Journal:  J Natl Cancer Inst       Date:  1993-12-01       Impact factor: 13.506

Review 4.  The increasing incidence of non-Hodgkin's lymphoma (NHL): the possible role of sunlight.

Authors:  R Cartwright; R McNally; A Staines
Journal:  Leuk Lymphoma       Date:  1994-08

5.  Second cancers in patients with chronic lymphocytic leukemia.

Authors:  L B Travis; R E Curtis; B F Hankey; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1992-09-16       Impact factor: 13.506

Review 6.  Hodgkin's and non-Hodgkin's lymphomas.

Authors:  P Hartge; S S Devesa; J F Fraumeni
Journal:  Cancer Surv       Date:  1994

7.  Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989.

Authors:  A J Swerdlow; H H Storm; P D Sasieni
Journal:  Int J Cancer       Date:  1995-06-09       Impact factor: 7.396

8.  Evidence of an association between non-Hodgkin's lymphoma and skin cancer.

Authors:  J Adami; M Frisch; J Yuen; B Glimelius; M Melbye
Journal:  BMJ       Date:  1995-06-10

9.  New primary cancers after squamous cell skin cancer.

Authors:  M Frisch; M Melbye
Journal:  Am J Epidemiol       Date:  1995-05-15       Impact factor: 4.897

10.  Increase in the incidence of non-Hodgkin's lymphomas: evidence for a recent sharp increase in France independent of AIDS.

Authors:  P M Carli; M C Boutron; M Maynadié; F Bailly; D Caillot; T Petrella
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more
  33 in total

1.  Mutual Risks of Cutaneous Melanoma and Specific Lymphoid Neoplasms: Second Cancer Occurrence and Survival.

Authors:  Megan M Herr; Sara J Schonfeld; Graça M Dores; Diana R Withrow; Margaret A Tucker; Rochelle E Curtis; Lindsay M Morton
Journal:  J Natl Cancer Inst       Date:  2018-11-01       Impact factor: 13.506

2.  A real-world, community-based cohort study comparing the effectiveness of topical fluorouracil versus topical imiquimod for the treatment of actinic keratosis.

Authors:  Romain Neugebauer; Katherine A Levandoski; Zheng Zhu; Monica Sokil; Mary-Margaret Chren; Gary D Friedman; Maryam M Asgari
Journal:  J Am Acad Dermatol       Date:  2017-12-24       Impact factor: 11.527

3.  Delineation of clinical and biological factors associated with cutaneous squamous cell carcinoma among patients with chronic lymphocytic leukemia.

Authors:  Geffen Kleinstern; Abdul Rishi; Sara J Achenbach; Kari G Rabe; Neil E Kay; Tait D Shanafelt; Wei Ding; Joe F Leis; Aaron D Norman; Timothy G Call; James R Cerhan; Sameer A Parikh; Christian L Baum; Susan L Slager
Journal:  J Am Acad Dermatol       Date:  2020-07-16       Impact factor: 11.527

4.  A unique case of merkel cell carcinoma and chronic lymphocytic leukaemia presenting in a single cutaneous lesion (collision tumour).

Authors:  Hailing Zhang; Gunjan Gupta; Xiao Yan Yang; Richard Rosenbluth; Pritish K Bhattacharyya
Journal:  BMJ Case Rep       Date:  2009-04-07

5.  UV irradiation augments lymphoid malignancies in mice with one functional copy of wild-type p53.

Authors:  W Jiang; H N Ananthaswamy; H K Muller; A Ouhtit; S Bolshakov; S E Ullrich; A K El-Naggar; M L Kripke
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

6.  Sunlight exposure in association with risk of lymphoid malignancy: a meta-analysis of observational studies.

Authors:  Hong-Bae Kim; Jung-Ha Kim
Journal:  Cancer Causes Control       Date:  2021-02-19       Impact factor: 2.506

Review 7.  [Simultaneous squamous cell carcinoma and follicular lymphoma of the tonsil].

Authors:  A E Albers; M Hummel; U Keilholz; G Tzamalis
Journal:  HNO       Date:  2010-12       Impact factor: 1.284

8.  Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.

Authors:  Romain Neugebauer; Katherine A Su; Zheng Zhu; Monica Sokil; Mary-Margaret Chren; Gary D Friedman; Maryam M Asgari
Journal:  J Am Acad Dermatol       Date:  2018-11-17       Impact factor: 11.527

9.  Comprehensive Evaluation of Medical Conditions Associated with Risk of Non-Hodgkin Lymphoma using Medicare Claims ("MedWAS").

Authors:  Eric A Engels; Ruth Parsons; Caroline Besson; Lindsay M Morton; Lindsey Enewold; Winnie Ricker; Elizabeth L Yanik; Hannah Arem; April A Austin; Ruth M Pfeiffer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-04-26       Impact factor: 4.254

Review 10.  Immunologic monitoring in chronic lymphocytic leukemia.

Authors:  William G Wierda
Journal:  Curr Oncol Rep       Date:  2003-09       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.